The DOI matches its Crossref record; the references it cites are not checked yet.
Behavioral or neuropsychiatric symptoms of Alzheimer’s disease: from psychopathology to pharmacological management.
Open accessAbstract
Neuropsychiatric or behavioral symptoms of dementia encompass a series of disorders, such as anxiety, depression, apathy, psychosis, and agitation, all commonly present in individuals living with dementia. While they are not required for the diagnosis of Alzheimer's disease (AD), they are ubiquitously present in all stages of the disease, contributing to negative clinical outcomes, including cognitive decline, functional disability, and caregiver burden. Neuropsychiatric symptoms have been conceptualized not only as risk factors but as clinical markers of decline along the AD spectrum. The concept of “mild behavioral impairment”, the behavioral correlate of mild cognitive impairment, has been proposed within this framework. The first steps in the management of behavioral symptoms in AD involve defining the target and investigating potential causes and/or aggravating factors. Once these factors are addressed, non-pharmacological approaches are preferred as first-line interventions. Following the optimization of anticholinesterase treatments, specific pharmacological approaches (e.g., antidepressants, antipsychotics) can be considered weighing potential side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Methylphenidate significantly improves apathy without major adverse events for a period of 3 months according to a research study.46”
From A 2025 update on treatment strategies for the Alzheimer’s disease spectrum (2025) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 88 · Cited by 33
Metadata
- Authors
- Teixeira, A. L., Rocha, N. P., & Gatchel, J.
- Affiliations
- University of Texas University of Texas Health Science Center, McGovern Medical School, Department of Psychiatry and Behavioral Sciences, Neuropsychiatry Program, Houston, Texas, United States.
- University of Texas Health Science Center, McGovern Medical School, Department of Neurology, Houston, Texas, United States.
- Michael E. DeBakey VA Medical Center (US)
- Venue
- Arquivos de Neuro-Psiquiatria
- Publisher
- Georg Thieme Verlag KG
- Published
- 2023-12
- Volume
- 81
- Issue
- 12
- Pages
- 1152-1162
- ISSN
- 0004-282X (ISSN-L)
- 1678-4227
- PMC
- PMC10756775
- OpenAlex
- W4390430964
- Cited by
- 33
- References
- 88
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 7 · 2023: 2
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Arquivos de Neuro-Psiquiatria (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Texas Alzheimer's Research and Care Consortium (TARCC 2020-23-93-II)
- National Institutes of Health
- National Institute on Aging (K23AG058805, AG072380-01A1, R21AG072380, R01AG078191)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- Alzheimer's disease, neuropsychiatric symptoms, behavioral symptoms of dementia, agitation, psychosis, depression, anxiety, apathy, mild behavioral impairment, mild cognitive impairment, non-pharmacological treatment, cholinesterase inhibitors, antidepressants, antipsychotic drugs, caregiver burden, functional disability
- MeSH terms
- Alzheimer Disease, Anxiety, Mental Disorders, Behavioral Symptoms, Humans, Antipsychotic Agents, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Behavioral or neuropsychiatric symptoms of Alzheimer’s disease: from psychopathology to pharmacological management. https://app.cochat.ai/papers/10.1055/s-0043-1777774
- The paper
- Teixeira, A. L., Rocha, N. P., & Gatchel, J. (2023). Behavioral or neuropsychiatric symptoms of Alzheimer’s disease: from psychopathology to pharmacological management. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1055/s-0043-1777774
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.